We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 360

DOJ and FDA Continue to Feast on Producers of Contaminated Foods
  • Paul Hastings LLP
  • USA
  • November 23 2016

On November 15, 2016, a United States District Judge sentenced the ownerpresident of Oasis Brands, Inc. (“Oasis”), Christian Rivas, to 15-months’

Southern District of Florida Rules that 180-Day Notice of Commercial Marketing Is Mandatory When Parties "Patent Dance"
  • Jones Day
  • USA
  • December 15 2015

On December 9, 2015, United States District Court Judge James Cohn, in the Amgen v. Apotex Neulasta litigation, granted Amgen's motion for a

Long-term Care legislation in Florida
  • Holland & Knight LLP
  • USA
  • May 28 2015

Long-term care companies in Florida need to review their regulatory compliance plans to see if updates are needed in light of several bills that

Florida cases accusing Bodacious Foods, Kashi of “all natural” mislabeling to continue
  • Shook Hardy & Bacon LLP
  • USA
  • September 12 2014

A Florida federal court has rejected a motion to dismiss in a case accusing Bodacious Foods of labeling its cookies as "all natural" despite

$3.2-million award upheld in wheat- and gluten-free products dispute
  • Shook Hardy & Bacon LLP
  • USA
  • February 7 2014

A federal court in Florida has denied the post-trial motions filed by a company that was found in breach of a manufacturing contract for supplying

Federal court rejects punitive damages in bone drug litigation
  • Shook Hardy & Bacon LLP
  • USA
  • August 1 2013

A federal court in Florida has granted a drug maker's request to apply New Jersey law to the plaintiffs' punitive damages demand in litigation

New medical device preemption win
  • Reed Smith LLP
  • USA
  • May 24 2013

We've read Kaiser v. DePuy Spine, Inc., ___ F. Supp.2d ___, 2013 WL 2006122 (M.D. Fla. May 14, 2013), which granted a motion to dismiss with

Putting it all together
  • Dechert LLP
  • USA
  • March 30 2012

Our first reaction upon reading Metz v. Wyeth, 2012 U.S. Dist. Lexis 42432 (M.D. Fla. March 28, 2012), is boy, this case has a little of everything!

U.S. district judge rejects FDA’s attempted regulatory authority over compounding pharmacies in United States v. Franck's Lab, Inc.
  • Duane Morris LLP
  • USA
  • September 20 2011

On September 12, 2011, the U.S. District Court for the Middle District of Florida in United States v. Franck's Lab, Inc. denied a request by the U.S. Food and Drug Administration ("FDA") for an injunction and summary judgment against a compounding pharmacy, Franck's, and firmly rejected the FDA's contention that it had per se authority to regulate pharmacies compounding drugs for animal use

FDA lacks authority to enjoin traditional animal drug compounding
  • King & Spalding LLP
  • USA
  • September 19 2011

On September 12, 2011, the United States District Court for the Middle District of Florida entered an order denying the U.S. Food and Drug Administration’s request for an injunction barring Franck’s Lab, a Floridabased pharmacy, from engaging in traditional, state-licensed bulk compounding of animal drugs and granting Franck’s motion for summary judgment